Abstract

Outsourcing bioinformatics is one of the most consequential decisions a research team makes  and one of the least structured. Sequencing quality is quantifiable upfront; bioinformatics quality is a blind spot until it compromises your results" - is this ok? A poorly executed RNA-Seq analysis does not fail loudly. It produces plausible-looking results that collapse under reviewer scrutiny, cannot be reproduced six months later, or quietly introduce batch effects that invalidate an entire study.

The bioinformatics services market is crowded. CROs(Contract Research Organization), academic cores, freelance analysts, and AI-branded platforms all compete for the same contracts  with vastly different levels of rigor, transparency, and scientific depth. Most researchers hire based on price and turnaround time alone, without a framework for evaluating what they are actually buying.

This blog gives you that framework. Ten questions  each one a filter that separates serious providers from superficial ones. Ask every prospective bioinformatics vendor these questions before signing a contract. The answers will tell you everything you need to know. And where relevant, this guide shows you exactly how Genix.ai's BioCompute service answers each one.

The 10 Questions Every Researcher Must Ask

Question 1  Who Actually Reviews My Results?

The most important question and the one most providers avoid answering directly. Many bioinformatics services are operationally tiered a junior analyst runs automated scripts, and a project manager reviews the PDF before sending it out. No PhD-level scientist ever looks at your data.

At Genix.ai BioCompute, a PhD credentialed analyst reviews every deliverable before it leaves the team. Not a template. Not an automated report generator. A trained genomics scientist who can distinguish a biologically meaningful result from a technical artifact  and who understands the difference between a volcano plot that tells a story and one that obscures it.

Ask this question first. If the answer is vague, walk away.

Question 2  What Tools Are in Your Pipeline, and Which Versions?

A serious bioinformatics provider publishes their toolchain. Vague answers like "industry standard tools" or "custom AI pipeline" are red flags. You need to know exactly which software, which version, and which parameters were used  because a reviewer will ask, and reproducibility depends on it.

Genix.ai BioCompute's RNA-Seq pipeline is explicit FastQC + MultiQC for QC, fastp or Trimmomatic for trimming, STAR for splice aware alignment, Salmon or featureCounts for quantification, DESeq2 or edgeR for differential expression, and clusterProfiler for GO, KEGG, and GSEA enrichment. Every tool version is logged. Every parameter is documented. The methods section delivered with your report is copy paste ready for journal submission.

If a provider cannot name their tools, they cannot reproduce their results.

Question 3  Can You Show Me a Sample Report?

Not a marketing brochure. Not a case study. An actual sample analysis report  the kind your lab would receive after submitting FASTQ files. This single request eliminates roughly half of all bioinformatics vendors immediately.

A professional sample report includes raw QC metrics, trimming statistics, alignment rates per sample, a normalized count matrix, a filtered DE gene list with adjusted p values, volcano and MA plots, PCA clustering, pathway enrichment dotplots, and a written methods section. Genix.ai provides sample reports on request before any commitment  because a provider confident in their quality has no reason to hide it.

Question 4  Who Owns the Data, the Code, and the Results?

Intellectual property clauses in bioinformatics contracts are frequently overlooked and occasionally catastrophic. Some providers retain rights to aggregate your data for model training. Others claim co authorship. A few have no explicit policy at all, which means disputes default to whichever party has better lawyers.

Genix.ai BioCompute operates under full NDA before any data transfer. You retain 100% ownership of all results, all code, all figures, and all raw analysis files. Data is deleted on project completion or retained for a defined period if you prefer. No authorship requirements. No data aggregation. No ambiguity.

Own your science. Get this in writing from every provider before you share a single FASTQ file.

Question 5  What Is Your Quality Control Standard for FASTQ Files?

Not all FASTQ files are created equal, and not all providers treat them with equal care. A provider that accepts your raw files and moves directly to alignment without QC is a provider that will deliver results built on contaminated, adapter laden, or low complexity reads.

Ask specifically Do you run FastQC before and after trimming? Do you flag samples with alignment rates below 70%? Do you pause the project and notify the client when QC metrics indicate a library preparation problem? Genix.ai answers yes to all three. QC is not a checkbox  it is the first formal deliverable, and it determines whether downstream analysis is worth running at all.

Question 6  How Do You Handle Non Human Organisms?

Many bioinformatics platforms are quietly human only. Their pipelines are built around GRCh38, and requests for mouse, zebrafish, Arabidopsis, or nonmodel organisms are routed to manual processes that break reproducibility guarantees.

Genix.ai BioCompute works with any organism that has a reference genome or transcriptome  human, mouse, rat, zebrafish, Arabidopsis, rice, bacteria, fungi, and viruses. For non model organisms without an established reference, de novo assembly workflows are available. If your biology is not human, confirm organism support explicitly before engaging any provider.

Question 7  What Happens When Results Are Unexpected?

Low alignment rates. Outlier samples. Batch effects that overwhelm biological signals. PCA plots where your conditions do not separate. These are not rare events they are regular features of real world RNA-Seq data. The question is whether your provider has a protocol for them or simply delivers the output and invoices you.

Genix.ai shares interim results before final delivery, specifically to catch and address unexpected findings early. One round of revisions is included in every project. If a sample fails QC, you are notified before analysis proceeds. If batch correction is needed, it is applied with documented methodology  not silently ignored.

Question 8  Can You Write My Methods Section?

This question separates data processors from scientific collaborators. A bioinformatics provider that deeply understands what they have done should be able to write a complete, journal ready methods section describing every tool, version, parameter, and statistical test  formatted to the conventions of Nature, Cell, or your target journal.

Every Genix.ai BioCompute RNA-Seq project includes a copy paste ready methods section as a standard deliverable. Not a generic template. A specific, accurate, reviewable account of what was run on your data. This alone saves most lab hours of manuscript preparation.

Question 9  What Is Your Actual Turnaround Time, and What Guarantees It?

Marketing pages say three to five days. Reality is often three to five weeks, especially when providers are understaffed or overbooked. Ask for a specific  Service Level Agreement in writing, and ask what happens if the deadline is missed.

Genix.ai BioCompute publishes transparent per assay turnaround times Bulk RNA-Seq in 3 to 5 days, WGS/WES in 5 to 7 days, single cell RNA-Seq in 7 to 10 days. These are commitments backed by a defined workflow and a team sized to meet demand. Rush delivery in 48 hours is available at a stated surcharge  no hidden conditions.

Question 10  How Does Your Pricing Scale, and What Is Actually Included?

The lowest per sample price is rarely the lowest total cost. Providers that advertise $50 per sample frequently charge separately for QC reports, pathway analysis, figure preparation, methods writing, revisions, and data transfer. The final invoice looks nothing like the quote.

Genix.ai BioCompute publishes all inclusive pricing  Bulk RNA-Seq from $150 per sample for 50+ samples, with QC, alignment, DE analysis, pathway enrichment, publication figures, methods section, raw files, and one revision round all included. Volume tiers, monthly retainers, and academic pricing are available and stated upfront. The quote you receive is the invoice you pay.

Conclusion: Why Genix.ai BioCompute Answers Every Question

These ten questions are not hypothetical. They are the exact standards by which Genix.ai's BioCompute NGS Analysis service was built  because the founding team came from research environments where inadequate bioinformatics delayed publications, failed grant renewals, and produced results that could not survive peer review.

Genix.ai BioCompute offers RNA-Seq, WGS, WES, single cell RNA-Seq, ChIP-Seq, ATAC-Seq, metagenomics, and multiomics integration  all under validated framework, with PhD review on every project, full IP ownership, NDA-protected data handling, and publication ready deliverables in 3 to 7 days. Starting at $150 per sample, it is 50 to 70% lower cost than Western bioinformatics CROs without compromising on depth, reproducibility, or scientific credibility.

Before you hire anyone else, ask these ten questions. Then compare the answers.

FAQs

1. What is the biggest mistake researchers make when hiring a bioinformatics provider?

 Choosing on price alone without verifying pipeline transparency, tool versioning, or who reviews the final results.

2. Does Genix.ai BioCompute support RNA-Seq analysis from non-human organisms? 

Yes  Genix.ai supports any organism with a reference genome, including mouse, zebrafish, Arabidopsis, bacteria, and custom de novo assemblies.

3. What is included in Genix.ai's RNA-Seq analysis price? 

QC, alignment, quantification, differential expression, pathway enrichment, publication figures, methods section, raw files, and one revision round  all included.

4. How do I transfer large FASTQ files to Genix.ai securely? 

Genix.ai accepts uploads via SFTP, AWS S3, Google Drive, Dropbox, BaseSpace, or SRA accession numbers under full NDA.

5. Does Genix.ai provide a sample report before I commit? 

Yes  sample reports are available on request so researchers can evaluate deliverable quality before any financial commitment.